Please see the letter to the editor below questioning a recent paper authored by John J Halperin who has been named in the racketeering lawsuit. A copy of this letter was sent to the president of the institution Halperin is employed. If this was a sexual harassment case Halperin would have been fired (not downplaying the seriousness of sexual harassment). This crime against humanity must end and those responsible must be held accountable. You might want to consider writing your own respectful letter of concern to the Chief Compliance Officer of Atlantic Health System and carbon copy the president as well. Eva Goldenberg, Esq., CHC, Chief Compliance Officer: eva.goldenberg@atlantichealth.org Brian Gragnolati, President and CEO of Atlantic Health System: bg7@ahsys.org Letter to the editor of Expert Review of Anti-infective Therapy: ---------- Original Message ---------- From: Carl Tuttle To: Hodan.Ibrahim@tandf.co.uk, enquiries@taylorandfrancis.com Cc: bg7@ahsys.org, john.halperin@atlantichealth.org, ddutko@hanszenlaporte.com Date: December 27, 2017 at 12:43 PM Subject: Diagnosis and management of Lyme neuroborreliosis Diagnosis and management of Lyme neuroborreliosis John J Halperin Pages 1-7 | Received 16 Sep 2017, Accepted 12 Dec 2017, Published online: 26 Dec 2017 http://www.tandfonline.com/doi/full/10.1080/14787210.2018.1417836 Dec 27, 2017 Taylor & Francis Group 2&4 Park Square Milton Park Abingdon OX14 4RN Attn: Hodan Ibrahim, Commissioning Editor for Expert Review of Anti-infective Therapy Dear Ms. Ibrahim, I would like to call attention to the following statement found in the Halperin paper: “….there is no evidence that prolonged post-treatment neurocognitive symptoms are related to nervous system infection - either as a triggering event or as a cause of ongoing symptoms.” You might want to read the following case study from Stony Brook Lyme Clinic. I understand the patient received thirteen spinal taps, multiple courses of IV and oral meds, and relapsed after each one, proven by CSF antigens and/or PCR. The only way this patient (said to be a physician) remained in remission was to keep her on open ended clarithromycin- was on it for 22 months by the time of publication. Seronegative Chronic Relapsing Neuroborreliosis. https://www.ncbi.nlm.nih.gov/pubmed/7796837 Lawrence C.a · Lipton R.B.b · Lowy F.D.c · Coyle P.K.d aDepartment of Medicine, bDepartment of Neurology, and cDivision of Infectious Diseases, Albert Einstein College of Medicine, and dDepartment of Neurology, State University of New York at Stony Brook, New York, NY., USA Eur Neurol 1995; 35:113–117 (DOI:10.1159/000117104) Abstract We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen. ________________________ You may want to ask Dr. Halperin why he excluded this case study from his so-called “expert review.” Might I remind you Ms. Ibrahim that selective use of literature, only citing studies supporting Halperin’s viewpoint cannot be considered an unbiased critical review. Please see the attached letter addressed to CDC Director Brenda Fitzgerald, MD highlighting yet another case of persistent infection after antibiotic treatment along with autopsy reports showing histopathologic findings consistent with neurologic manifestations of chronic Lyme disease. Letter to CDC Director Fitzgerald: https://www.dropbox.com/s/xaul84dqmqgbre0/Brenda%20Fitzgerald%20MD%20Director%20CDC.docx?dl=0 Please be advised that John J Halperin has been named in a racketeering lawsuit here in the United States. The court document can be found at the following link: (I suggest you read it) https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf Respectfully submitted, Carl Tuttle Independent Researcher Lyme endemic Hudson, NH USA Cc: John J Halperin, Medical Director of Neuroscience for Atlantic Health System Brian Gragnolati, President and CEO of Atlantic Health System Daniel R. Dutko, HANSZEN LAPORTE __________________________________ Letter to the Chief Compliance Officer of Atlantic Health System: --------- Original Message ---------- From: Carl Tuttle To: eva.goldenberg@atlantichealth.org Date: December 27, 2017 at 2:48 PM Subject: Code of Ethics and Corporate Compliance Program Dec 27, 2017 Atlantic Health System Corporate Compliance & Internal Audit 475 South Street Morristown, NJ 07960 Attn: Eva Goldenberg, Esq., CHC Vice President, Corporate Compliance and Internal Audit, Chief Compliance Officer, Privacy Officer, Research Integrity Officer Dear Ms. Goldenberg, The following directive was taken from your Code of Ethics and Corporate Compliance Program Guide: https://www.atlantichealth.org/content/dam/atlantichealth/Public/Documents/Code%20of%20Ethics.pdf Mandatory Reporting: AHS is committed to ensuring that it properly addresses suspected violations of law, regulation, policy, procedure, or the Code of Ethics. Atlantic Health System relies upon its Personnel to report possible issues so that it may take appropriate action. Per the letter below, please be advised that Dr. John J Halperin, Medical Director of Neuroscience for Atlantic Health System has been named in a racketeering lawsuit. Sincerely, -Carl Tuttle Hudson, NH